Previous close | 22.95 |
Open | 22.86 |
Bid | 21.12 x 100 |
Ask | 21.75 x 100 |
Day's range | 21.21 - 23.00 |
52-week range | 4.84 - 27.72 |
Volume | |
Avg. volume | 199,816 |
Market cap | 989.656M |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
It's shaping up to be a tough period for Silence Therapeutics plc ( NASDAQ:SLN ), which a week ago released some...
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript March 13, 2024 Silence Therapeutics plc misses on earnings expectations. Reported EPS is $-0.47 EPS, expectations were $-0.25. SLN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]